1. Home
  2. XBIO vs CHNR Comparison

XBIO vs CHNR Comparison

Compare XBIO & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • CHNR
  • Stock Information
  • Founded
  • XBIO N/A
  • CHNR N/A
  • Country
  • XBIO United States
  • CHNR China
  • Employees
  • XBIO N/A
  • CHNR N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • CHNR Precious Metals
  • Sector
  • XBIO Health Care
  • CHNR Basic Materials
  • Exchange
  • XBIO Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • XBIO 4.2M
  • CHNR 4.6M
  • IPO Year
  • XBIO N/A
  • CHNR 1995
  • Fundamental
  • Price
  • XBIO $4.08
  • CHNR $3.68
  • Analyst Decision
  • XBIO Hold
  • CHNR
  • Analyst Count
  • XBIO 1
  • CHNR 0
  • Target Price
  • XBIO N/A
  • CHNR N/A
  • AVG Volume (30 Days)
  • XBIO 187.0K
  • CHNR 37.8K
  • Earning Date
  • XBIO 08-12-2025
  • CHNR 05-15-2025
  • Dividend Yield
  • XBIO N/A
  • CHNR N/A
  • EPS Growth
  • XBIO N/A
  • CHNR N/A
  • EPS
  • XBIO N/A
  • CHNR N/A
  • Revenue
  • XBIO $2,582,728.00
  • CHNR N/A
  • Revenue This Year
  • XBIO $14.23
  • CHNR N/A
  • Revenue Next Year
  • XBIO $7.14
  • CHNR N/A
  • P/E Ratio
  • XBIO N/A
  • CHNR N/A
  • Revenue Growth
  • XBIO 5.63
  • CHNR N/A
  • 52 Week Low
  • XBIO $2.20
  • CHNR $3.35
  • 52 Week High
  • XBIO $5.27
  • CHNR $9.04
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 61.16
  • CHNR 43.59
  • Support Level
  • XBIO $3.44
  • CHNR $3.35
  • Resistance Level
  • XBIO $4.46
  • CHNR $3.71
  • Average True Range (ATR)
  • XBIO 0.63
  • CHNR 0.30
  • MACD
  • XBIO 0.05
  • CHNR -0.03
  • Stochastic Oscillator
  • XBIO 54.79
  • CHNR 29.41

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About CHNR China Natural Resources Inc.

China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.

Share on Social Networks: